Prolonged Nightly Fasting in Breast Cancer Survivors

Inclusion Criteria

• •Participants must have a documented history of histologically confirmed invasive breast cancer.
• •Participants with a history of stage I to III invasive breast cancer, and no current evidence of disease.
• •A history of bilateral breast cancer is allowed provided the patient is currently disease free, with stage I to III disease on both sides.
• •No evidence of distant metastatic disease or unresectable locally recurrent disease
• •All adjuvant or neoadjuvant cytotoxic chemotherapy, radiation, and surgery for breast cancer must have been completed at least 6 month prior to registration. Except:
• •* Adjuvant hormonal therapy is permitted. Must have been on for a minimum of 1 month.
• •* Adjuvant trastuzumab, pertuzumab, TDM1, or neratinib for Her2 positive breast cancer is permitted Age ≥18 years.
• •Participant must be female.
• •Ability to understand and the willingness to sign a written informed consent document